Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya.

ABSTRACT:

Background

Mortality from TB continues to be a global public health challenge. TB ranks alongside Human Immunodeficiency Virus (HIV) as the leading infectious causes of death globally. HIV is a major driver of TB related morbidity and mortality while TB is the leading cause of mortality among people living with HIV/AIDS. We sought to determine excess mortality associated with HIV and the effect of antiretroviral therapy on reducing mortality among tuberculosis patients in Kenya.

Methods

We conducted a retrospective analysis of Kenya national tuberculosis program data of patients enrolled from 2013 through 2014. We used direct standardization to obtain standardized mortality ratios for tuberculosis patients compared with the general population. We calculated the population at

SUBMITTER: Onyango DO 

PROVIDER: S-EPMC5690617 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature